How can understanding clonal selection aid in the development of personalized immunotherapies?

By identifying and expanding lymphocyte clones specific to the patient's unique cancer antigens.

By suppressing immune responses to reduce side effects.

By generating generic immune responses suitable for all patients.

By focusing solely on innate immune responses.